CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Deutsche Bank 36th Annual Health Care Conference, being held May 2-4 2011 at the InterContinental Hotel in Boston, MA. Mr. Christensen will provide a corporate update regarding the Company’s three major business franchises and value drivers - KALBITOR® (ecallantide), the Licensing and Funded Research Program (LFRP) and the internal pipeline, including label expansion efforts with KALBITOR. The Dyax presentation is scheduled for Monday, May 2 at 10:00 AM ET.
